|

TB-500 25 mg (Thymosin Beta-4)

Description

Biochem TB-500 25 mg (Thymosin Beta-4) – Synthetic Peptide

Biochem TB-500 25 mg is a formulation labeled as containing TB-500, a synthetic peptide associated with the biological activity of thymosin beta-4 (Tβ4), a naturally occurring peptide involved in actin regulation, cellular migration, tissue remodeling, and wound-healing processes.

Thymosin beta-4 is a highly conserved peptide found in numerous mammalian tissues and cell types. It is particularly associated with intracellular actin regulation and has been studied for its involvement in cellular movement, cytoskeletal organization, and responses to tissue injury.

The term TB-500 is commonly used in the peptide market to describe compounds related to thymosin beta-4. However, TB-500 does not always identify a single, universally standardized molecular structure. Some products contain synthetic full-length thymosin beta-4, while others may contain shorter peptide fragments or modified sequences.

Full-length human thymosin beta-4 consists of 43 amino acid residues and has a molecular weight of approximately 4,963.5 Da. Its biological properties are associated with interactions involving actin and several cellular pathways relevant to tissue organization and repair.

Thymosin beta-4 has been studied in experimental models involving wound healing, cellular migration, angiogenesis, inflammation, and tissue regeneration. Certain pharmaceutical formulations of thymosin beta-4 have also undergone human clinical evaluation, particularly for ocular surface conditions and wound-related applications.

However, results obtained with full-length thymosin beta-4 cannot automatically be applied to every product marketed as TB-500, particularly when the exact amino acid sequence and molecular identity have not been verified.

Unlike anabolic-androgenic steroids, growth hormone secretagogues, or conventional metabolic hormone agonists, TB-500-related peptides are studied primarily for their interactions with cellular structural proteins and biological processes associated with tissue remodeling.

The Biochem TB-500 formulation contains a labeled quantity of 25 mg per vial. The precise peptide sequence, molecular identity, excipients, physical presentation, and manufacturing specifications have not been independently verified.

SpecificationDetails
Product NameBiochem TB-500
Alternative NamesTB500 / Thymosin Beta-4-Related Peptide / Tβ4-Related Peptide
Active IngredientTB-500, Exact Molecular Identity Not Confirmed
Strength25 mg per vial
Total Active Ingredient25 mg
Peptide ClassificationThymosin Beta-4-Related Peptide
Molecular ClassificationSynthetic Peptide
Reference Biological MoleculeHuman Thymosin Beta-4
Amino Acid Length43 Residues for Full-Length Human Thymosin Beta-4
Reference Amino Acid SequenceAc-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES
Molecular FormulaC₂₁₂H₃₅₀N₅₆O₇₈S for Full-Length Human Thymosin Beta-4
Approximate Molecular Weight4,963.5 Da for Full-Length Human Thymosin Beta-4
Biological OriginSynthetic Compound Related to a Naturally Occurring Mammalian Peptide
Primary Molecular InteractionActin Binding and Cytoskeletal Regulation
Primary Biological PathwaysCellular Migration, Tissue Remodeling, and Wound-Response Signaling
Vial SizeNot Specified
FormulationNot Confirmed
Compound ClassificationCytoskeletal and Tissue-Response-Associated Peptide
Primary Area of StudyCellular Migration, Wound Healing, and Tissue Repair Biology
Biological ActivitySequence-Dependent; Not Independently Confirmed for This Product
AdministrationFormulation-Dependent
Release ProfileNot Established for the Specified Product

1. Participates in Actin Regulation

Full-length thymosin beta-4 interacts with monomeric globular actin (G-actin), contributing to the regulation of actin availability and cytoskeletal dynamics. These processes are important for maintaining cellular structure and supporting cellular movement.

2. Influences Cellular Migration

Thymosin beta-4 has been studied for its effects on the migration of several cell types involved in tissue maintenance and repair. Cellular migration is an essential component of normal wound healing and tissue remodeling.

3. Has Been Examined in Wound-Healing Models

Experimental studies have examined thymosin beta-4 in models of skin injury, corneal damage, and other tissue-repair processes. Certain findings suggest effects on cellular migration and wound closure, although outcomes depend on the model, peptide identity, and formulation.

4. Participates in Cytoskeletal Organization

Actin is a fundamental component of the cellular cytoskeleton. Through its interaction with actin, thymosin beta-4 participates in processes associated with cell shape, intracellular organization, and movement.

5. Has Been Studied in Angiogenesis-Associated Processes

Thymosin beta-4 has been examined for its involvement in endothelial cell migration and biological processes associated with blood vessel formation. These findings are primarily associated with experimental tissue-repair models and do not establish predictable therapeutic effects from commercial TB-500 preparations.

6. Has Been Examined in Inflammatory Response Models

Experimental studies have investigated thymosin beta-4 in relation to inflammatory signaling and tissue responses following injury. Some models have reported changes in inflammatory markers, but the clinical significance of these findings remains dependent on the specific condition and preparation studied.

7. Has Been Investigated in Musculoskeletal and Tissue Remodeling Models

Thymosin beta-4-related compounds have attracted scientific interest in studies involving skeletal muscle, connective tissue, and other tissue-remodeling processes. However, controlled human evidence does not establish that commercially marketed TB-500 reliably accelerates tendon healing, ligament repair, muscle recovery, or recovery from sports injuries.

The biological properties of thymosin beta-4 are not interchangeable with those of every TB-500-labeled product. Molecular identity, peptide sequence, purity, formulation, and exposure all influence biological activity. Human clinical evidence for systemic TB-500 preparations remains limited, and their long-term effects are not adequately characterized.

Thymosin beta-4 participates in biological processes involving actin regulation and cellular responses to tissue injury. Its activity differs from conventional receptor agonists because an important established interaction involves the actin cytoskeleton rather than a single, well-defined hormone receptor.

Step 1 – Introduction Into the Biological System

A TB-500-related peptide enters the biological environment according to its formulation and route of administration. Absorption, stability, and tissue distribution depend on the exact molecular structure and preparation.

Step 2 – Interaction With Cellular Components

Full-length thymosin beta-4 interacts with G-actin, an important structural protein involved in cytoskeletal organization. The extent to which a particular TB-500 preparation reproduces this interaction depends on its amino acid sequence.

Step 3 – Regulation of Actin Dynamics

Thymosin beta-4 participates in the regulation of actin monomer availability, which contributes to the dynamic organization of the cellular cytoskeleton.

These processes are relevant to cellular movement, structural changes, and normal tissue maintenance.

Step 4 – Influence on Cellular Migration and Tissue Responses

Through actin-associated processes and additional biological interactions, thymosin beta-4 has been studied for its influence on cellular migration, endothelial responses, and wound-related tissue remodeling.

The mechanisms responsible for all reported effects have not been completely established.

Step 5 – Peptide Metabolism and Elimination

Thymosin beta-4-related peptides may undergo enzymatic degradation through physiological peptide metabolism pathways.

The rate of degradation, systemic exposure, and elimination depends on the exact peptide structure, formulation, and route of administration.

A validated elimination half-life for Biochem TB-500 25 mg has not been established. Published pharmacokinetic findings for other thymosin beta-4 preparations should not automatically be applied to this product.

TB-500 formulations differ from anabolic steroid oil solutions and conventional small-molecule compounds because they contain synthetic peptides whose stability and biological activity depend on their molecular structure.

Their formulation characteristics may include:

  • TB-500 as the labeled active ingredient.
  • A labeled quantity of 25 mg per vial.
  • A peptide associated with thymosin beta-4 biology.
  • Sequence-dependent interactions with cellular structural proteins.
  • Biological pathways associated with actin regulation and cellular migration.
  • Lyophilized or liquid presentations, depending on the formulation.
  • Excipients selected to support peptide stability.
  • Formulation-dependent sensitivity to temperature, moisture, pH, and degradation.
  • Packaging and storage requirements determined by the product composition.
  • Molecular identity and purity requiring analytical confirmation.

The precise peptide sequence, formulation, excipient composition, and manufacturing specifications of Biochem TB-500 25 mg have not been confirmed.

Formulation ingredients do not independently produce the biological activity associated with thymosin beta-4. The molecular properties listed for full-length thymosin beta-4 are reference characteristics and should not be interpreted as confirmation that the Biochem product contains that exact molecule.


United States

Biochem TB-500 25mg, Biochem TB500 25mg USA, TB-500 25mg United States, Thymosin Beta-4 25mg, TB-500 peptide 25mg, TB500 25mg vial, thymosin beta-4 peptide, TB-500 properties, TB-500 description, TB-500 how it works, TB-500 composition, TB-500 pharmacology, TB-500 actin regulation, TB-500 cellular migration, TB-500 wound healing studies, TB-500 tissue remodeling, TB-500 cytoskeletal function, TB-500 angiogenesis studies, TB-500 molecular structure, TB-500 mechanism of action, thymosin beta-4 biological activity.

Canada

English: Biochem TB-500 25mg Canada, TB500 peptide 25mg Canada, Thymosin Beta-4 25mg Canada, TB-500 25mg vial, TB-500 properties, TB-500 formulation, TB-500 actin regulation, TB-500 cellular migration, TB-500 wound healing studies, TB-500 tissue remodeling, thymosin beta-4 peptide composition.

French: Biochem TB-500 25 mg Canada, thymosine bêta-4 25 mg, peptide TB-500 25 mg, flacon TB-500 25 mg, propriétés du TB-500, composition du TB-500, régulation de l'actine, migration cellulaire, cicatrisation des tissus, remodelage tissulaire, cytosquelette cellulaire, mécanisme d'action de la thymosine bêta-4.

United Kingdom

Biochem TB-500 25mg UK, TB500 peptide 25mg UK, Thymosin Beta-4 25mg UK, TB-500 25mg vial UK, TB-500 properties, TB-500 pharmacology, TB-500 actin binding, TB-500 cellular migration, TB-500 wound healing studies, TB-500 tissue remodelling, TB-500 cytoskeletal regulation, TB-500 peptide composition, TB-500 mechanism of action.

Germany

Biochem TB-500 25 mg Deutschland, Thymosin Beta-4 25 mg, TB-500 Peptid 25 mg, TB-500 25 mg Fläschchen, TB-500 Eigenschaften, TB-500 Wirkungsmechanismus, TB-500 Zusammensetzung, Aktinregulation, Zellmigration, Wundheilungsforschung, Gewebeumbau, Zytoskelettfunktion, Angiogeneseforschung, Thymosin Beta-4 Peptidstruktur.

France

Biochem TB-500 25 mg France, thymosine bêta-4 25 mg, peptide TB-500 25 mg, flacon TB-500 25 mg, propriétés du TB-500, mécanisme d'action du TB-500, composition du TB-500, régulation de l'actine, migration cellulaire, cicatrisation des tissus, remodelage tissulaire, cytosquelette cellulaire, angiogenèse, structure du peptide thymosine bêta-4.

Spain

Biochem TB-500 25 mg España, timosina beta-4 25 mg, péptido TB-500 25 mg, vial TB-500 25 mg, propiedades del TB-500, cómo funciona el TB-500, composición del TB-500, regulación de actina, migración celular, cicatrización de tejidos, remodelación tisular, función del citoesqueleto, angiogénesis, estudios de reparación de tejidos, mecanismo de acción del TB-500.

Italy

Biochem TB-500 25 mg Italia, timosina beta-4 25 mg, peptide TB-500 25 mg, flaconcino TB-500 25 mg, proprietà del TB-500, meccanismo d'azione TB-500, composizione del TB-500, regolazione dell'actina, migrazione cellulare, cicatrizzazione dei tessuti, rimodellamento tissutale, funzione del citoscheletro, angiogenesi, struttura del peptide timosina beta-4.

Portugal

Biochem TB-500 25 mg Portugal, timosina beta-4 25 mg, peptídeo TB-500 25 mg, frasco TB-500 25 mg, propriedades do TB-500, mecanismo de ação TB-500, composição do TB-500, regulação da actina, migração celular, cicatrização de tecidos, remodelação tecidual, função do citoesqueleto, angiogénese, estudos de reparação de tecidos, estrutura do peptídeo TB-500.

Netherlands

Biochem TB-500 25 mg Nederland, thymosine bèta-4 25 mg, TB-500 peptide 25 mg, TB-500 25 mg flacon, eigenschappen van TB-500, werkingsmechanisme TB-500, samenstelling van TB-500, actineregulatie, celmigratie, wondgenezing, weefselremodellering, cytoskeletfunctie, angiogenese, TB-500 peptidestructuur.

Belgium

Biochem TB-500 25 mg Belgium, TB-500 25 mg België, TB-500 25 mg Belgique, thymosine bèta-4, thymosine bêta-4, eigenschappen van TB-500, propriétés du TB-500, actineregulatie, régulation de l'actine, celmigratie, migration cellulaire, wondgenezing, cicatrisation, weefselremodellering, remodelage tissulaire, cytoskeletfunctie.

Switzerland

Biochem TB-500 25 mg Switzerland, TB-500 25 mg Schweiz, TB-500 25 mg Suisse, Thymosin Beta-4, thymosine bêta-4, TB-500 Eigenschaften, propriétés du TB-500, Aktinregulation, régulation de l'actine, Zellmigration, migration cellulaire, Wundheilung, cicatrisation, Gewebeumbau, remodelage tissulaire.

Austria

Biochem TB-500 25 mg Österreich, Thymosin Beta-4 25 mg, TB-500 Peptid 25 mg, TB-500 25 mg Fläschchen, TB-500 Eigenschaften, TB-500 Wirkungsmechanismus, Aktinregulation, Zellmigration, Wundheilungsforschung, Gewebeumbau, Zytoskelettfunktion, Angiogeneseforschung, TB-500 Zusammensetzung.

Sweden

Biochem TB-500 25 mg Sverige, tymosin beta-4 25 mg, TB-500 peptid 25 mg, TB-500 25 mg injektionsflaska, TB-500 egenskaper, TB-500 verkningsmekanism, aktinreglering, cellmigration, sårläkning, vävnadsremodellering, cytoskelettfunktion, angiogenes, vävnadsreparation, TB-500 peptidstruktur.

Norway

Biochem TB-500 25 mg Norge, tymosin beta-4 25 mg, TB-500 peptid 25 mg, TB-500 25 mg hetteglass, TB-500 egenskaper, TB-500 virkningsmekanisme, aktinregulering, cellemigrasjon, sårheling, vevsremodellering, cytoskjelettfunksjon, angiogenese, vevsreparasjon, TB-500 peptidstruktur.

Denmark

Biochem TB-500 25 mg Danmark, thymosin beta-4 25 mg, TB-500 peptid 25 mg, TB-500 25 mg hætteglas, TB-500 egenskaber, TB-500 virkningsmekanisme, aktinregulering, cellemigration, sårheling, vævsremodellering, cytoskeletfunktion, angiogenese, vævsreparation, TB-500 peptidstruktur.

Finland

Biochem TB-500 25 mg Suomi, tymosiini beeta-4 25 mg, TB-500 peptidi 25 mg, TB-500 25 mg injektiopullo, TB-500 ominaisuudet, TB-500 vaikutusmekanismi, aktiinin säätely, solujen migraatio, haavan paraneminen, kudosten uudelleenmuodostuminen, solun tukiranka, angiogeneesi, kudoskorjaus, TB-500 peptidirakenne.

Poland

Biochem TB-500 25 mg Polska, tymozyna beta-4 25 mg, peptyd TB-500 25 mg, fiolka TB-500 25 mg, właściwości TB-500, mechanizm działania TB-500, skład TB-500, regulacja aktyny, migracja komórek, gojenie ran, przebudowa tkanek, funkcja cytoszkieletu, angiogeneza, badania regeneracji tkanek, struktura peptydu TB-500.

Czech Republic

Biochem TB-500 25 mg Česko, thymosin beta-4 25 mg, peptid TB-500 25 mg, lahvička TB-500 25 mg, vlastnosti TB-500, mechanismus účinku TB-500, složení TB-500, regulace aktinu, buněčná migrace, hojení ran, remodelace tkání, funkce cytoskeletu, angiogeneze, výzkum obnovy tkání, struktura peptidu TB-500.

Romania

Biochem TB-500 25 mg România, timozină beta-4 25 mg, peptidă TB-500 25 mg, flacon TB-500 25 mg, proprietăți TB-500, mecanism de acțiune TB-500, compoziția TB-500, reglarea actinei, migrarea celulară, vindecarea rănilor, remodelarea țesuturilor, funcția citoscheletului, angiogeneză, studii de reparare a țesuturilor, structura peptidei TB-500.

Greece

Biochem TB-500 25 mg Ελλάδα, θυμοσίνη βήτα-4 25 mg, πεπτίδιο TB-500 25 mg, φιαλίδιο TB-500 25 mg, ιδιότητες TB-500, μηχανισμός δράσης TB-500, σύνθεση TB-500, ρύθμιση ακτίνης, κυτταρική μετανάστευση, επούλωση τραυμάτων, αναδιαμόρφωση ιστών, λειτουργία κυτταροσκελετού, αγγειογένεση, έρευνα αποκατάστασης ιστών, δομή πεπτιδίου TB-500.

Ireland

Biochem TB-500 25mg Ireland, TB500 peptide 25mg Ireland, Thymosin Beta-4 25mg Ireland, TB-500 25mg vial Ireland, TB-500 properties, TB-500 pharmacology, TB-500 actin binding, TB-500 cellular migration, TB-500 wound healing studies, TB-500 tissue remodelling, TB-500 cytoskeletal regulation, TB-500 peptide composition, TB-500 mechanism of action.


Colombia

Biochem TB-500 25 mg Colombia, timosina beta-4 25 mg Colombia, péptido TB-500 25 mg, vial TB-500 25 mg, propiedades del TB-500, cómo funciona el TB-500, farmacología del TB-500, composición del TB-500, regulación de actina, migración celular, cicatrización de tejidos, remodelación tisular, función del citoesqueleto, angiogénesis, estudios de reparación de tejidos, mecanismo de acción del TB-500, descripción del TB-500.

Argentina

Biochem TB-500 25 mg Argentina, timosina beta-4 25 mg Argentina, péptido TB-500 25 mg, vial TB-500 25 mg, propiedades del TB-500, qué es el TB-500, cómo actúa el TB-500, farmacología del TB-500, regulación de actina, migración celular, cicatrización de tejidos, remodelación tisular, función del citoesqueleto, angiogénesis, composición del TB-500.

México

Biochem TB-500 25 mg México, timosina beta-4 25 mg México, péptido TB-500 25 mg, vial TB-500 25 mg, propiedades del TB-500, para qué se estudia el TB-500, cómo funciona el TB-500, farmacología del TB-500, regulación de actina, migración celular, cicatrización de tejidos, remodelación tisular, función del citoesqueleto, angiogénesis, mecanismo de acción del TB-500.

Perú

Biochem TB-500 25 mg Perú, timosina beta-4 25 mg Perú, péptido TB-500 25 mg, vial TB-500 25 mg, propiedades del TB-500, qué es el TB-500, cómo funciona el TB-500, farmacología del TB-500, regulación de actina, migración celular, cicatrización de tejidos, remodelación tisular, función del citoesqueleto, angiogénesis, composición del TB-500.

Venezuela

Biochem TB-500 25 mg Venezuela, timosina beta-4 25 mg Venezuela, péptido TB-500 25 mg, vial TB-500 25 mg, propiedades del TB-500, qué es el TB-500, cómo actúa el TB-500, farmacología del TB-500, regulación de actina, migración celular, cicatrización de tejidos, remodelación tisular, función del citoesqueleto, angiogénesis, composición del TB-500.

Ecuador

Biochem TB-500 25 mg Ecuador, timosina beta-4 25 mg Ecuador, péptido TB-500 25 mg, vial TB-500 25 mg, propiedades del TB-500, para qué se estudia el TB-500, cómo funciona el TB-500, farmacología del TB-500, regulación de actina, migración celular, cicatrización de tejidos, remodelación tisular, función del citoesqueleto, angiogénesis, composición del TB-500, mecanismo de acción del TB-500, descripción del TB-500.


Biochem TB-500 25mg | Thymosin Beta-4-Related Peptide

Learn about Biochem TB-500 25mg, a thymosin beta-4-related peptide associated with actin regulation, cellular migration, tissue remodeling, and wound-healing research.

Biochem TB-500 25mg | Péptido Relacionado con Timosina Beta-4

Conoce Biochem TB-500 25mg, un péptido relacionado con la timosina beta-4, estudiado por su participación en la regulación de actina, la migración celular y la remodelación de tejidos.

biochem-tb-500-25mg-thymosin-beta-4-peptide

biochem-tb-500-25mg-peptido-timosina-beta-4

Biochem TB-500 25mg peptide vial labeled as containing TB-500, a thymosin beta-4-related synthetic peptide associated with actin regulation, cellular migration, cytoskeletal organization, and tissue remodeling studies.

Biochem TB-500 25mg vial de péptido etiquetado como TB-500, un péptido sintético relacionado con la timosina beta-4, asociado con la regulación de actina, la migración celular, la organización del citoesqueleto y los estudios de remodelación tisular.